<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03869580</url>
  </required_header>
  <id_info>
    <org_study_id>P/2018/396</org_study_id>
    <nct_id>NCT03869580</nct_id>
  </id_info>
  <brief_title>Incidence and Factors Associated With Double-J Urinary Stent Infection (IJJ)</brief_title>
  <acronym>IJJ</acronym>
  <official_title>Incidence and Factors Associated With Double-J Urinary Stent Infection (IJJ)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study was to determine the incidence and factors associated with double-J
      urinary stent infection.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2019</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">April 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with urinary tract infection associated with double J stent</measure>
    <time_frame>6 months</time_frame>
    <description>Number of patients with urinary tract infection associated with double J stent</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients with specific clinical data associated with urinary tract infection associated with double J stent</measure>
    <time_frame>6 months</time_frame>
    <description>Clinical data (Age, sex, gender, comorbidities, indication of procedure, duration of double J stent placement) will be compared between patient with urinary tract infection and no urinary tract infection associated with double J stent</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of patients with relapse and/or recurrence after a first urinary tract infection</measure>
    <time_frame>6 months</time_frame>
    <description>Number of patients with relapse and/or recurrence after a first urinary tract infection</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">800</enrollment>
  <condition>Double J Stent</condition>
  <arm_group>
    <arm_group_label>Stent infection</arm_group_label>
    <description>Patients diagnosed with urinary tract infection associated with double J stent</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No stent infection</arm_group_label>
    <description>Patients with double J stent without infection during the study period</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with a double-J stent placement or change in the hospital will be included.

        Follow-up will be repeated at 1, 3 and 6 months and urinary tract infection will be
        reported
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a double-J stent placement or change in the hospital

        Exclusion Criteria:

          -  renal transplants less than one year old
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>CHU de Besançon</name>
      <address>
        <city>Besançon</city>
        <zip>25000</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>March 4, 2019</study_first_submitted>
  <study_first_submitted_qc>March 8, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 11, 2019</study_first_posted>
  <last_update_submitted>March 8, 2019</last_update_submitted>
  <last_update_submitted_qc>March 8, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 11, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

